THE TGA has implemented a new measure in response to the shortage of Orencia (abatacept) 125mg single dose syringe and the 125mg ClickJect autoinjector for subcutaneous injection.
Effective from yesterday, a Serious Scarcity Substitution Instrument (SSSI) has been introduced by TGA.
The SSSI empowers Australian pharmacists to substitute one form of the medication for the other where appropriate, without requiring a new prescription from the prescriber.
The TGA stated this adjustment is designed to ensure pharmacy customers continue to receive their essential medication without interruption amid supply challenges.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 May 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 May 24
